Select a city Select a city

Rinetra - Rinetra Nasal Spray 15ml

#107250_2080
 0 (0 review)
Characteristics
Status
Select a city
Find it at the pharmacyPharmacies
BrandWorld Medicine / World Medicine
Brand country Turkey
Quantity and shape1 vial
Genericsphenyleprine+dexamethasone+neomycin+polymixin B sulfate
Volume15მლ
Short description
Used for inflammatory and infectious diseases of the nasal cavity, pharynx, and paranasal sinuses.
32.00₾
1
Package
Select a city
To generate delivery methods
Similar products
  • Description
  • Reviews

Rinetra

Name of the medicinal product

Rinetra, Rinetra

International Nonproprietary Name or Group Name

Neomycin + Polymyxin B + Dexamethasone + Phenylephrine

Neomycin + Polymyxin В + Dexamethasone + Phenylephrine   

Composition

1 ml of the preparation contains

Active substance: neomycin sulfate 6500 IU, polymyxin B sulfate 10000 IU, dexamethasone sodium metasulfobenzoate 0.25 mg, phenylephrine hydrochloride 2.5 mg.

Excipients: methyl parahydroxybenzoate, sodium chloride, citric acid monohydrate, macrogol 4000, polysorbate 80, sodium hydroxide, purified water.

Dosage form

Nasal spray.

Description: clear, colorless or slightly yellowish solution.

Indications for use

Inflammatory and infectious diseases of the nasal cavity, pharynx, paranasal sinuses:

- acute and chronic rhinitis;

- Acute and chronic rhinopharyngitis;

- Sinusitis.

Method of administration and doses

Dosage

Adults: one spray in each nostril 3-5 times a day.

For children from 2.5 to 18 years of age: one spray in each nostril  3 times a day.

The duration of treatment is 5-10 days.

Method of use

Rinetra spray is intended for intranasal use only.

When using the bottle should be held vertically  with the nozzle pointing upwards.

Contraindications

- Hypersensitivity to the active substances of the drug or any excipient;

- Suspected closed-angle glaucoma;

- Simultaneous use of monoamine oxidase (MAO) inhibitors;

- Viral diseases;

- Kidney diseases accompanied by albuminuria;

- Renal failure;

- Pregnancy;

- Lactation;

- Children under 2.5 years of age.

Rinetra is contraindicated during pregnancy and lactation.

Effect on the ability to drive vehicles and operate machinery

Data on the negative effect of the drug on the ability to drive vehicles and operate machinery does not exist.

Overdose

Due to the low degree of absorption into the systemic blood circulation, overdose is unlikely.

Pharmacodynamic properties

Pharmacotherapeutic group: Decongestants and other nasal preparations for topical use. Dexamethasone in combination. ATC code: R01AD53

Rinetra is a combined preparation for local use in otorhinolaryngology. It has the anti-inflammatory effect of dexamethasone on the nasal mucosa and the antibacterial effect of neomycin and polymyxin B.

Dexamethasone is well absorbed during local use and its absorption increases during inflammation of the mucous membrane. In the specified combination of antibiotics, the spectrum of antibacterial activity is broadened against most gram-positive and gram-negative microorganisms that cause infectious and inflammatory diseases of the nasal cavity and paranasal sinuses.

Pharmacokinetic properties

No data available.

Shelf life

3 years from the date of production.

Do not use after the expiry date.

Special instructions for storage

Store at a temperature not exceeding 25°C.

Keep out of the reach of children!

Type and contents of packaging

15 ml nasal spray in a white plastic bottle with a dosing device and a protective cap or 15 ml in a yellow glass bottle with a dosing device and a protective cap.

1 bottle together with the instruction for medical use in a cardboard box.

Also, see: Neladex - Neladex Ns Ns Nasal Spray 15ml

Translated by AI